Axiron is now officially off the shelf, there is no cash flow for Acrux.
Now the question is on the other major brand Androgel : if they don't submit the NDA and pull off either, there will be NO testosterone products on the market to meet the huge medical demand.
Interesting ACR board has been hiding this potential bad news for so long.
Ann: Axiron License Agreement Terminated, page-15
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
-0.001(1.30%) |
Mkt cap ! $22.09M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 8.0¢ | 7.6¢ | $20.57K | 261.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 42206 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 39473 | 1 |
View Market Depth
| Last trade - 15.59pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.7¢ |
Change
-0.001 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| 8.1¢ | 8.1¢ | 7.7¢ | 138671 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| ACR (ASX) Chart |